Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett W Carter

Showing results (121-130 of 171) with videos related to

Pageof 18
Sort By:
Journal of the American College of Radiology : JACR|March 13, 2026
ACR Appropriateness Criteria® Staging and Follow-Up of Melanoma, Christopher Mejias, Rustain L Morgan, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance statusJoao V Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, et al.
Journal of the American College of Radiology : JACR|May 7, 2021
ACR Appropriateness Criteria® Imaging of Mediastinal Masses, Jeanne B Ackman, Jonathan H Chung, et al.
Journal of the American College of Radiology : JACR|August 4, 2019
Evaluation of Cancer Patients With Suspected Pulmonary Embolism: Performance of the American College of Physicians GuidelineAiham Qdaisat, Sai-Ching J Yeung, Darshan E Variyam, et al.
Clinical Lung Cancer|February 26, 2022
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung CancerMehmet Altan, Eric K Singhi, Michelle Worst, et al.
Journal of the American College of Radiology : JACR|May 7, 2020
ACR Appropriateness Criteria® Occupational Lung Diseases, Christian W Cox, Jonathan H Chung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2018
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural MesotheliomaAnne S Tsao, Heather Lin, Brett W Carter, et al.
Journal of the American College of Radiology : JACR|May 6, 2019
ACR Appropriateness Criteria<sup>®</sup> Noninvasive Clinical Staging of Primary Lung Cancer, Patricia M de Groot, Jonathan H Chung, et al.
Journal of the American College of Radiology : JACR|November 6, 2019
ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompromised Patients, Christopher Lee, Patrick M Colletti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2021
Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II TrialYasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.
Pageof 18

Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
Journal of the American College of Radiology : JACR|March 13, 2026
ACR Appropriateness Criteria® Staging and Follow-Up of Melanoma, Christopher Mejias, Rustain L Morgan, et al.
Journal for Immunotherapy of Cancer|August 6, 2020
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance statusJoao V Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, et al.
Journal of the American College of Radiology : JACR|May 7, 2021
ACR Appropriateness Criteria® Imaging of Mediastinal Masses, Jeanne B Ackman, Jonathan H Chung, et al.
Journal of the American College of Radiology : JACR|August 4, 2019
Evaluation of Cancer Patients With Suspected Pulmonary Embolism: Performance of the American College of Physicians GuidelineAiham Qdaisat, Sai-Ching J Yeung, Darshan E Variyam, et al.
Clinical Lung Cancer|February 26, 2022
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung CancerMehmet Altan, Eric K Singhi, Michelle Worst, et al.
Journal of the American College of Radiology : JACR|May 7, 2020
ACR Appropriateness Criteria® Occupational Lung Diseases, Christian W Cox, Jonathan H Chung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2018
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural MesotheliomaAnne S Tsao, Heather Lin, Brett W Carter, et al.
Journal of the American College of Radiology : JACR|May 6, 2019
ACR Appropriateness Criteria<sup>®</sup> Noninvasive Clinical Staging of Primary Lung Cancer, Patricia M de Groot, Jonathan H Chung, et al.
Journal of the American College of Radiology : JACR|November 6, 2019
ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompromised Patients, Christopher Lee, Patrick M Colletti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2021
Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II TrialYasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.
Pageof 18